Prevalence of Human Papillomavirus Among Females After Vaccine Introduction—National Health and Nutrition Examination Survey, United States, 2003–2014

Prevalence of Genital Human Papillomavirus in Males, United States, 2013–2014

(2017) Julia W. Gargano et al.   JOURNAL OF INFECTIOUS DISEASES

Ecological Association of Human Papillomavirus Vaccination with Cervical Dysplasia Prevalence in the United States, 2007–2014

(2016) Elaine W. Flagg et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community

(2016) Jessica A. Kahn et al.   CLINICAL INFECTIOUS DISEASES

Prevalence of HPV After Introduction of the Vaccination Program in the United States

(2016) Lauri E. Markowitz et al.   PEDIATRICS

Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices

(2016) Elissa Meites et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2015

(2016) Sarah Reagan-Steiner et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis

(2015) Mélanie Drolet et al.   LANCET INFECTIOUS DISEASES

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types

(2014) K Kavanagh et al.   BRITISH JOURNAL OF CANCER

Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study

(2014) Sepehr N Tabrizi et al.   LANCET INFECTIOUS DISEASES

Prevalence of Anogenital Warts Among Participants in Private Health Plans in the United States, 2003–2010: Potential Impact of Human Papillomavirus Vaccination

(2013) Elaine W. Flagg et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010

(2013) Lauri E. Markowitz et al.   JOURNAL OF INFECTIOUS DISEASES

Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels

(2013) Ahmedin Jemal et al.   JNCI-Journal of the National Cancer Institute

Vaccine-Type Human Papillomavirus and Evidence of Herd Protection After Vaccine Introduction

(2012) J. A. Kahn et al.   PEDIATRICS

"Herd Immunity": A Rough Guide

(2011) P. Fine et al.   CLINICAL INFECTIOUS DISEASES

Prevalence of Genital Human Papillomavirus Among Females in the United States, the National Health and Nutrition Examination Survey, 2003–2006

(2011) Susan Hariri et al.   JOURNAL OF INFECTIOUS DISEASES

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

(2011) Cosette M Wheeler et al.   LANCET ONCOLOGY

Estimating Model-Adjusted Risks, Risk Differences, and Risk Ratios From Complex Survey Data

(2010) G. S. Bieler et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

(2009) Darron R. Brown et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET